Cutting Edge Information Recommends Companies Increase KOL Communication to Lessen Impact From Sunshine Act
Although some companies find the logistical pain subsiding under the Sunshine Act, operational challenges loom. Companies that have already begun publishing physician payments will have to alter some of their disclosures to provide more transparency. This increased transparency may drive some KOLs away from working with the industry.
Companies that have not begun to publicly disclose physician payments have a lot of catching up to do. The good news for these companies is that drug makers will not need to report any transfers of value until January 1, 2012, so there is time to outline plans.
5/24/2010 12:49:59 AM